Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.
Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.
Another group of researchers has concluded that proton pump inhibitors (PPIs) such as Prevacid, Nexium and Prilosec, may not be safe for the kidneys and are warning doctors to use caution when prescribing them. “Present study however gives two important guidelines or indications PPI can produce renal damage with or without concurrent administration of other drugs. Especially in nephrology unit patients, caution must be exercised while using PPI,” write the authors of a study just published in the International Journal of Basic & Clinical Pharmacology. Earlier this year, two different academic studies were published linking the very popular acid reducing drugs to kidney ... Read More
Dietary supplement marketers who outsource manufacturing of their products to a third party should have a close relationship with their suppliers so they can be sure the ingredients in their products are safe, legal and disclosed to consumers, the Food and Drug Administration (FDA) advised during the Rocky Mountain Dietary Supplement Forum in Bolder, Colo. “I think if you’re not going to manufacture your product alone, or formulate it, that … it would be very beneficial to have a close relationship with your supplier so you can answer questions that are going to come to you during an audit,” said Nancy ... Read More
People who take atypical antipsychotics may lower their risk of developing type 2 diabetes by adding a vitamin D supplement to their regimen, according to a new study published in Scientific Reports. Atypical antipsychotics, such as Risperidal, are used to treat a variety of psychiatric disorders including schizophrenia, bipolar disorder, and irritability with autism. They are also used off-label to treat behavioral conditions such as ADHD and Tourette’s syndrome. The medications have been linked to metabolic disturbances that can decrease insulin sensitivity, leading to weight gain and new-onset type 2 diabetes. The drugs can also increase levels of the pregnancy hormone ... Read More
Health Canada, the country’s regulator of pharmaceuticals and medical devices, is recommending stricter rules for the popular painkiller acetaminophen, available by prescription and over-the-counter under brand names such as Tylenol, to cut down on the risk of life threatening side effects. The new rules advise patients not to exceed the recommended dosage of four grams per day for regular-strength pills or eight tablets of extra-strength acetaminophen. The agency is also recommending that the medicine not be taken more than five days to treat pain, or three days for fever. Manufacturers of the pain killer who currently have stock of the ... Read More
Pregnant women have been lead to believe that the painkiller Tylenol (acetaminophen) is a safe for developing fetuses, but two new studies show that prenatal exposure to the widely used medicine can increase the risk of asthma or hyperactivity by the time that child reaches 7 years of age. The first study, published in the International Journal of Epidemiology, evaluated more than 53,000 children from the Norwegian Mother and Child Cohort Study for current asthma at ages 3 and 7. Researchers also noted maternal use of acetaminophen during pregnancy. They found that women who used the pain reliever while pregnant increased ... Read More
Medication side effects can be significantly more severe in children than adults, leading to prolonged hospitalization, permanent disability or death. For this reason, it is a justified separate focus in the list of patient safety challenges in the Actionable Patient Safety Solutions (APSS) to be addressed at the Patient Safety Movement’s 5th Annual World Patient Safety, Science and Technology Summit in February 2017. The Pediatric Adverse Drug Events challenge was identified during the Midyear Planning Meeting, which brought together more than 100 medical experts, administrators, patient advocates, and government officials from around the world. The meeting concluded with a discussion and vote to ... Read More
There is more movement in the growing litigation involving injuries allegedly caused by the type 2 diabetes drug Invokana. Plaintiffs with claims pending in the Philadelphia Court of Common Pleas are seeking to consolidate their claims into a mass tort program. Currently, 87 cases are pending in Philadelphia. They are reportedly virtually identical. Consolidating them would cut down on legal costs and increase efficiency. Meanwhile, a motion was filed with the U.S. Judicial Panel on Multidistrict Litigation (MDL) Requesting that federal claims be consolidated into the Trenton Division of the U.S. District Court of the District of New Jersey. At least ... Read More
The Warnings and Precautions section of the anti platelet drug Brilinta has been updated to include a new risk of bradyarrhthmia, or slow heart rate of under 60 beats per minute. Brilinta, known chemically as ticagrelor, is manufactured by AstraZeneca. It is in a class of medications known as P2Y12 platelet inhibitors. Brilinta is used to reduce the rate of cardiovascular death, myocardial infraction (heart attack), and strokes in patients with acute coronary syndrome or with a history of heart attacks. It is also indicated to reduce the rate of stent thrombosis in patients who have been stented for acute coronary ... Read More
The deadline for filing Xarelto lawsuits alleging bleeding injuries with the popular blood thinner has been extended 90 days for certain plaintiffs groups due to an influx of complaints that have reportedly inundated the clerk’s office, Judge Eldon Fallon ordered. Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer are facing more than 7,000 lawsuits in a multidistrict litigation alleging the companies’ blood thinner Xarelto caused major bleeding events including gastrointestinal bleeds and brain hemorrhages. Four bellwether trials have already been scheduled for 2017. Another 950 lawsuits have been consolidated into a mass tort program in Pennsylvania with the first scheduled ... Read More
Dietary supplements are used by more than 180 million Americans each day, and it is up to the Food and Drug Administration (FDA) to ensure they do not cause harm. But this can be challenging since the FDA’s authority to regulate dietary supplements is vastly different than the agency’s authority to regulate pharmaceutical agents and medical devices. It is a daunting process with more than 85,000 dietary supplements on the market. In 1994, the Dietary Supplement Health and Education Act made dietary supplement manufacturers responsible for ensuring that their products were safe. Under this law, manufacturers do not need FDA ... Read More